Published in Health and Medicine Week, December 19th, 2005
"Targeted inhibition of oncogenes in tumor cells is a rational approach toward the development of cancer therapies based on RNAi," wrote L.N. Putral and colleagues, University of Queensland.
"Tumors caused by HPV infection are an ideal model system for RNAi-based cancer therapies because the oncogenes that cause cervical cancer, E6 and E7, are expressed only in cancerous cells."
The researchers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.